Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$415M |
| 2 |
Tesla
TSLA
|
+$360M |
| 3 |
Capital One
COF
|
+$328M |
| 4 |
Johnson & Johnson
JNJ
|
+$168M |
| 5 |
EMA
Emera Incorporated
EMA
|
+$164M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$1.03B |
| 3 |
DFS
Discover Financial Services
DFS
|
+$296M |
| 4 |
Eli Lilly
LLY
|
+$215M |
| 5 |
Amazon
AMZN
|
+$205M |
Sector Composition
| 1 | Technology | 34.3% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 9.2% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Real Brokerage
REAX
$1.05B
| $53.1K | ﹤0.01% |
11,789
+674
| +6% | +$3.04K |
|
2702
MidWestOne Financial Group
MOFG
$609M
| $52.9K | ﹤0.01% |
1,840
+248
| +16% | +$7.14K |
|
2703
Mid Penn Bancorp
MPB
$691M
| $52.9K | ﹤0.01% |
1,877
+493
| +36% | +$13.9K |
|
2704
Ascendis Pharma
ASND
$12B
| $52.6K | ﹤0.01% |
305
-472
| -61% | -$81.5K |
|
|
MAZE
2705
Maze Therapeutics, Inc. Common Stock
MAZE
$702M
| $52K | ﹤0.01% |
4,242
+3,371
| +387% | +$41.4K |
|
|
SFD
2706
Smithfield Foods, Inc. Common Stock
SFD
$9.5B
| $51.9K | ﹤0.01% |
2,208
| – | – |
|
2707
Northrim BanCorp
NRIM
$508M
| $51.4K | ﹤0.01% |
551
+85
| +18% | +$7.93K |
|
2708
Myers Industries
MYE
$602M
| $51.3K | ﹤0.01% |
3,543
-2,435
| -41% | -$35.3K |
|
2709
Hippo Holdings
HIPO
$891M
| $51.1K | ﹤0.01% |
1,828
+75
| +4% | +$2.1K |
|
2710
United States Antimony
UAMY
$586M
| $51K | ﹤0.01% |
+23,405
| New | +$51K |
|
2711
Clearfield
CLFD
$456M
| $50.4K | ﹤0.01% |
1,160
-9,881
| -89% | -$429K |
|
|
ATYR
2712
aTyr Pharma
ATYR
$513M
| $48.5K | ﹤0.01% |
+9,570
| New | +$48.5K |
|
2713
Allient
ALNT
$774M
| $48.1K | ﹤0.01% |
1,326
+26
| +2% | +$944 |
|
2714
The Honest Company
HNST
$422M
| $48K | ﹤0.01% |
9,439
-16,973
| -64% | -$86.4K |
|
2715
Liberty Latin America Class A
LILA
$1.51B
| $47.7K | ﹤0.01% |
7,825
-19,115
| -71% | -$117K |
|
|
CTO
2716
CTO Realty Growth
CTO
$561M
| $47.6K | ﹤0.01% |
2,760
+283
| +11% | +$4.89K |
|
2717
KalVista Pharmaceuticals
KALV
$775M
| $47.5K | ﹤0.01% |
4,202
-4,338
| -51% | -$49K |
|
2718
Amylyx Pharmaceuticals
AMLX
$1.05B
| $47.4K | ﹤0.01% |
+7,402
| New | +$47.4K |
|
2719
ASP Isotopes
ASPI
$769M
| $47.3K | ﹤0.01% |
6,424
-60
| -0.9% | -$442 |
|
|
SAGE
2720
DELISTED
Sage Therapeutics
SAGE
| $47.2K | ﹤0.01% |
5,175
-4,571
| -47% | -$41.7K |
|
2721
SmartFinancial
SMBK
$627M
| $47.2K | ﹤0.01% |
1,396
-81
| -5% | -$2.74K |
|
|
HUYA
2722
Huya Inc
HUYA
$740M
| $47K | ﹤0.01% |
13,366
| – | – |
|
2723
Financial Institutions
FISI
$548M
| $46.9K | ﹤0.01% |
1,828
+236
| +15% | +$6.06K |
|
|
EU
2724
enCore Energy
EU
$438M
| $46.8K | ﹤0.01% |
16,363
-18,952
| -54% | -$54.2K |
|
2725
Shore Bancshares
SHBI
$567M
| $46.6K | ﹤0.01% |
2,964
+64
| +2% | +$1.01K |
|